Kothari Fermentation board to meet on May 29

1 min read     Updated on 21 May 2026, 04:42 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Kothari Fermentation & Biochem Ltd. will hold a board meeting on May 29, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The trading window is closed until 48 hours after the results are declared.

powered bylight_fuzz_icon
40907526

*this image is generated using AI for illustrative purposes only.

Kothari Fermentation & Biochem Ltd. has announced that its board of directors will meet on Friday, May 29, 2026. The primary agenda of the meeting is to consider and approve the audited financial results of the company for the quarter and fiscal year ended March 31, 2026. The meeting is being convened in compliance with Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Closure of Trading Window

In accordance with the company's Code of Conduct for Prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities remains closed. This restriction applies to all designated persons and their immediate relatives. The window will reopen 48 hours after the declaration of the audited financial results for the period ending March 31, 2026. The company had previously communicated this closure via a notice dated March 24, 2026.

Meeting Details

The board meeting will address the financial performance for the fourth quarter and the full financial year 2025-26. Along with the financial results, the board may also take up other business items as necessary during the session.

Event Details
Board Meeting Date May 29, 2026
Financial Period Quarter and Year ended March 31, 2026
Trading Window Status Closed till 48 hours post-result declaration
Regulatory Reference SEBI (LODR) Regulations, 2015

Historical Stock Returns for Kothari Fermentation & Biochem

1 Day5 Days1 Month6 Months1 Year5 Years
-2.49%+0.76%-4.67%-7.96%-49.49%-39.44%

How might Kothari Fermentation & Biochem's FY2025-26 revenue and profitability compare to the previous fiscal year, and what key growth drivers could influence investor sentiment post-results?

Will the board consider announcing dividends or any capital allocation decisions alongside the audited financial results on May 29, 2026?

How could the company's financial performance for FY2025-26 reflect broader trends in India's fermentation and biochemicals sector, particularly amid evolving demand for bio-based products?

Kothari Fermentation & Biochem
View Company Insights
View All News
like16
dislike

Kothari Fermentation & Biochem Ltd Board Approves Director Reappointments and Remuneration Revisions

1 min read     Updated on 08 Apr 2026, 02:25 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Kothari Fermentation & Biochem Ltd's board meeting on April 08, 2026, approved reappointment of Mr. Pramod Kumar Kothari as Chairman & Managing Director at Rs. 6,00,000/- monthly and Mrs. Kavita Devi Kothari as Whole Time Director at Rs. 5,75,000/- monthly. Both three-year appointments from April 1, 2026, to March 31, 2029, require shareholder approval and follow Nomination and Remuneration Committee recommendations.

powered bylight_fuzz_icon
37184100

*this image is generated using AI for illustrative purposes only.

Kothari Fermentation & Biochem Ltd announced significant board decisions regarding director reappointments and remuneration revisions following a board meeting held on April 08, 2026. The company, which operates as an ISO 22000:2018 and HALAL certified organization, disclosed these developments in compliance with SEBI regulations.

Board Meeting Outcomes

The Board of Directors convened on Wednesday, April 08, 2026, from 10:30 AM to 12:00 PM to deliberate on key appointments. The meeting resulted in approval of reappointments and remuneration revisions for two senior directors, based on recommendations from the Nomination and Remuneration Committee.

Director Reappointments and Remuneration Details

The board approved significant changes to the leadership structure:

Position Director New Monthly Remuneration Term Period
Chairman & Managing Director Mr. Pramod Kumar Kothari Rs. 6,00,000/- April 1, 2026 - March 31, 2029
Whole Time Director Mrs. Kavita Devi Kothari Rs. 5,75,000/- April 1, 2026 - March 31, 2029

Mr. Pramod Kumar Kothari Reappointment

Mr. Pramod Kumar Kothari (DIN: 00086145) has been reappointed as Chairman and Managing Director for a three-year term. His monthly remuneration has been revised to Rs. 6,00,000/-. The appointment makes him liable to retire by rotation and requires shareholder approval in the forthcoming general meeting.

Mrs. Kavita Devi Kothari Reappointment

Mrs. Kavita Devi Kothari (DIN: 00120415) has been reappointed as Whole Time Director with revised monthly remuneration of Rs. 5,75,000/-. Similar to the Chairman's appointment, her three-year term is subject to shareholder approval and ratification.

Family Relationships and Corporate Governance

The company disclosed important relationships between directors as required by regulations:

  • Mr. Pramod Kumar Kothari and Mrs. Kavita Devi Kothari are husband and wife
  • Both are parents of Mr. Siddhant Kothari, Whole-Time Director
  • Both are parents-in-law of Ms. Janhavi Kothari, Executive Director (Purchase Department)

Regulatory Compliance

The announcements comply with Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, and follow the company's Policy on Determination of Materiality of Events/Information. The company has also uploaded the intimation on its website at www.kothariyeast.in/investors for stakeholder access.

All appointments are contingent upon shareholder approval in the upcoming general meeting, ensuring proper corporate governance protocols are followed.

Historical Stock Returns for Kothari Fermentation & Biochem

1 Day5 Days1 Month6 Months1 Year5 Years
-2.49%+0.76%-4.67%-7.96%-49.49%-39.44%

How might the significant remuneration increases for both directors impact the company's operational costs and profitability margins over the next three years?

What strategic initiatives or expansion plans could justify the substantial salary revisions for the leadership team?

Will the concentration of family members in key executive positions raise any corporate governance concerns among institutional investors?

Kothari Fermentation & Biochem
View Company Insights
View All News
like15
dislike

More News on Kothari Fermentation & Biochem

1 Year Returns:-49.49%